Dynatrace 4Q26: Stable ARR Masks an Aggressive FY27 Acceleration Target – Stock Needs Proof, Not Promise

Core Conclusion

Dynatrace delivered its fourth consecutive quarter of 16% constant-currency ARR growth, but the FY27 guidance implies a step-change in net-new ARR (NNARR) growth from roughly 10% in 2H26 to 16-23%. The stock will likely trade sideways until investors see tangible evidence that the acceleration trajectory is achievable. We maintain an Equal-weight rating with a $40 price target, reflecting limited near-term upside and a show-me narrative.

Market May Underestimate Execution Risk vs. Guidance Optimism

The FY27 ARR guidance of 15.5-16.5% cc growth was ahead of consensus (14.7% reported), but it requires a material improvement in NNARR. This marks the first time in several years that initial guidance implies positive NNARR growth; prior years (FY24, FY25, FY26) guided to NNARR declines. The market may be giving management too much credit for a turnaround that is not yet visible in the underlying pace of new business. Net-new ARR grew only +9% cc in 4Q26 (vs. +11% in 3Q26), and the full-year FY26 NNARR growth was just +12% cc—hardly a springboard for a 16-23% acceleration. The burden of proof is squarely on management.

Evidence Chain: Stability Is Not Acceleration

ARR stabilization is real but momentum is not inflecting. ARR growth held at 16% cc for four consecutive quarters, and FY26 net-new ARR of +12% cc was a major improvement vs. the -1% and -9% declines in FY25 and FY24, respectively. Large deal momentum was solid: 22 deals over $1M in ARR, 9 from new customers, and new logo ARR surged +43% YoY (vs. +21% in 3Q26).

The FY27 guide requires a step-function improvement that lacks recent precedent. The implied NNARR growth of 16-23% stands in stark contrast to the 10% growth recorded in 2H26. Management cites supportive factors: healthy observability demand, DPS consumption growth above 20% YoY, a large DPS renewal cohort, logs growing 100%+ YoY (now >$100M run rate), and improving sales productivity. Yet the recent quarterly NNARR trend—decelerating from +11% to +9%—does not confirm an imminent re-acceleration.

NRR slipped to 110% from 111%, a subtle but negative signal. While still above 110%, NRR is not improving. Combined with the gross margin headwind from logs adoption (guide implies ~100 bps drag), the margin profile is also under mild pressure despite 50 bps operating margin expansion guide to 29.5%. This mix—revenue growth acceleration needed alongside gross margin compression—creates a fragile base for the FY27 target.

Key Disagreements and Risks

Bull Case: A large DPS renewal cohort and strong logs traction could drive net-new ARR acceleration starting in 1H27. If execution matches guidance, the stock could re-rate toward the bull case $56, which implies 21x CY27 FCF.

Bear Case: Observability commoditization, hyperscaler competition, or longer sales cycles in large enterprise deals could derail the NNARR target. Sales productivity improvements may not materialize fast enough. The bear case of $20 reflects 9x CY27 FCF.

Specific risks to monitor: (1) NNARR growth below 10% in any quarter would damage credibility; (2) NRR continues to drift below 110%; (3) gross margin erosion beyond guided headwind; (4) competition from Datadog or native cloud provider tools.

Valuation and Trading Implications

Our $40 price target is derived from 16x our base-case CY27e FCF/share of $2.28 (FCF ~$702M), plus net cash of $3.60/share. This multiple is below the software median growth-adjusted multiple of 0.73x vs. 0.81x (ours implies 16x vs. sector 12x CY27 FCF). The discount reflects the uncertainty around FY27 guidance achievability. At $39.21 close, the implied upside is only +2%, consistent with a show-me stance. Shares lack a near-term catalyst until the 1Q27 earnings report provides early read-through on NNARR trends.

Appendix: Key Metrics Summary